Dr. Ashwin Mallipatna, a pediatric ophthalmologist specializing in retinoblastoma, trained at St. John's Medical College and the Hospital for Sick Children in Toronto, where he received the Student Humanitarian Award in 2009. His research, particularly on periocular Topotecan, has been recognized internationally. Dr. Mallipatna has been instrumental in early detection methods and has collaborated worldwide to enhance retinoblastoma management. He co-founded Iksha Foundation to support care in India and played a key role in developing AJCC retinoblastoma staging, influencing global treatment standards. Currently, he`s an Assistant Professor and Head of the Retinoblastoma Program in Toronto, focusing on innovative early detection and treatment strategies.
Financial disclosure: Dr. Mallipatna has/had an affiliation (financial or otherwise) with a commercial organization:
1. Santen Pharmaceutical Co.
Sessions in which Ashwin Mallipatna, MBBS, MD participates
jueves 19 septiembre, 2024
Sessions in which Ashwin Mallipatna, MBBS, MD attends
jueves 15 junio, 2023
Admission to this session is included in the full registration fee. If you wish to attend this session as a stand-alone event only, please contact Rita Afeltra at rafeltra@cos-sco.ca to register.
Please join us for a glass of cheer and help us celebrate the 2023 COS Annual Meeting and Exhibition. This event is a great opportunity to network with our international speakers, special guests, sponsors, and exhibitors. Renew old acquaintances and make new friends with colleagues from across Canada.
viernes 16 junio, 2023
*Breakfast to be served from 6:00am* Learning Objectives:At the end of this session, participants will be able to:Identify innovative canadian retina research proposalsand their intended benefitDescribe how using emerging therapies can improvethe care of patientsCanMEDS Roles: Medical Expert, Scholar
This workshop will focus on the challenges and barriers that can prevent vulnerable populations from accessing eye care services, and the potential role of portable eye care technologies in addressing these challenges. It will include demonstrations of the use of portable eye care technologies and examination equipment, as well as presentations on successful programs and initiatives that have used these technologies to provide eye care services to refugees and those in shelter...
Authors: Mohammad A. Khan1, Simrat Sodhi2, Samantha Orr3, Austin Pereira4, Netan Choudhry3. 1McMaster University, 2Oxford University, 3VRMTO, 4University of Toronto.Author Disclosures: M.A. Khan: None. S. Sodhi: None. S. Orr: None. A. ...
Authors: Jeremy T. Moreau , Etienne Benard-Seguin, David Plemel, Michael Ashenhurst, Ezekiel Weis, Femida Kherani, Karim Punja, Andrew Ting, Fiona Costello. University of Calgary.Author Disclosures: J.T. Moreau: None. E. Benard-Seguin: None. D. Plemel: None. M. Ashenhurst: None. E. Weis: None. F. Kherani:&nbsp...
Learning Objectives:At the end of this session participants will be able to:Describe how bias, discrimination, and racism affect health care outcomes and physician wellness, and how cultural humility and critical allyship can be used as tools in combating discrimination
Authors: Andrei-Alexandru Szigiato , Sandeep Singh, Margaret Mills, Kimberly Baynes, Sumit Sharma, Careen Lowder, Peter Kaiser, Sunil Srivastava. Cole Eye Institute, Cleveland Clinic.Author Disclosures: A. Szigiato: None. S. Singh: None. M. Mills: None. K. Baynes: None. S. Sharma:&nb...
Author Block: Samir Touma , Badr Ait Hammou, Fares Antaki, Renaud Duval. University of Montreal.Author Disclosure Block: S. Touma: All other investments or relationships that could be seen by a reasonable, well-informed participant as having the potential to influence the content of the educational activity; Name of for-profit or not-for-profit organization(s); Bayer Inc.. All other investments or relationships that cou...
Authors: Grace S. Yin1, Zhuo Shao2, Hanna Faghfoury3, Brian G. Ballios4. 1Queen’s University School of Medicine, Queen’s University, ON, Canada, 2Genetics Program, North York General Hospital, University of Toronto, ON, Canada, 3Fred a Litwin and Family Center in Genetic Medicine, Department of Medicine, University of Toronto, ON, Canada, 4Department of Ophthalmology and Vision Sc...
sábado 17 junio, 2023
Learning ObjectivesAt the end of this session, participants will be able to:Understand what is meant by cortical visual impairment Appreciate the impact of visual impairment on mental healthBe able to assess the needs of a child with visual impairment CanMEDS Roles: Medical ...
Learning Objectives: At the end of this session, participants will be able to: Describe Choroidal findings in premature babies with ROP Describe the recent recommendations in paediatric CMV screeningDescribe the findings in opti...
Learning ObjectivesAt the end of this session participants will be able to:Describe the impact of AI technologies on eye care Understand the unique aspects of eye health needs in remote populations C...
Learning ObjectivesAt the end of this session, participants will be able to:Understand the pre and post-natal screening of retinoblastoma Learn the accuracy of IOL calculation formulas in Children
Authors: Ninglu Weng 1, Michael Richards2, Ian Clark2. 1Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 2Department of Ophthalmology, Max Rady College of Medicine, University of Manitoba.Author Disclosures: N. Weng: All other investments or relationships that could be seen by a reasonable, well-informed participant as having the potential to in...
Authors: Zhao Xun Feng1, Alp Polat2, Stephanie Kletke2, Ashwin Mallipatna2, Brenda Gallie2. 1Department of Ophthalmology, University of Ottawa, 2Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children.Author Disclosures: Z. Feng: None. A. Polat: None. S. Kletke: None. A. Mallipatna: None. B. ...
domingo 18 junio, 2023
Authors: Daniel Milad , Fares Antaki, Allison Bernstein, Samir Touma, Renaud Duval. Université de Montréal.Author Disclosures: D. Milad: None. F. Antaki: Funded grants or clinical trials; Name of for-profit or not-for-profit organization(s); ...